The Discovery and Proliferation of Amphetamines, Modern Day Prescription Stimulants, and Attention Deficit Disorder: The Person Who First Synthesized Amphetamines, How U.S. Chemist Gordon Alles Experimented Upon Himself With Amphetamines, Amphetamines Becoming Prescribed Medications, the First Amphetamine Medication Released by English Pharmaceutical Company Smith Kline & French, Post Secondary Students Abusing This First Amphetamine Medication, the English Military Studying Amphetamine Usage During World War II, the Use of Benzedrine (Amphetamine) Post World War II, Amphetamine Use by Creative Artists, How U.S. Novelist Jack Kerouac Began Using Amphetamines, the Nickname of U.S. Physician “Max Jacobson”, the Celebrity Patients of Jacobson, the True Meaning of the Doctor Robert Song by English Rock Band the Beetles, the Amphetamine Use of U.S. Artist Andy Warhol, the Consequence of Amphetamine Usage Dramatically Increasing During the 1960’s, the Number of Amphetamine Medications Produced Annually Per Person at the Zenith of Amphetamine Usage, the Decrease of Amphetamine Usage During the 1970’s, the Dual Classifications of Amphetamines, Methylphenidate (Ritalin) vs Amphetamines, How Stimulants Work Within the Human Body, the Effect of Utilizing Amphetamine Medication, the Benefit of Stimulant Medication, the Reason U.S. Professional Athletes Cannot Consume Amphetamines, the Only Method to Circumvent This Requirement, Professionals Utilizing Amphetamines to Advance Their Career, the Fastest Growing Segment of Attention Deficit Hyper Activity Disorder Patients, Prescription Amphetamine vs Illicit Methamphetamine, the Shared Commonality of Prescription Amphetamine and Illicit Methamphetamine, the Type of Work Which Utilizes the Most Amphetamine Medication, the Number of Children and Adolescents Consuming Amphetamine Medication During the 1990’s vs the Number of Children and Adolescents Consuming Amphetamine Medication During the 2010’s, the Volume of Children Diagnosed With Attention Deficit Hyper Activity Disorder Diagnosis Prior to Age 6, the Medical Argument for Medicating Children and Adolescents With Amphetamines, the Reason This Belief Was Incorrect, the Person Who Created Methylphenidate, the Reason Swiss Chemist Leandro Panizzon Wanted to Create a Stimulant Medication, the Etymology of “Ritalin”, the Small Change Swiss Chemical Manufacture Chemische Industrie Basel (CIBA) Made to Methylphenidate, the First Controlled Study of Methylphenidate, the Tool U.S. Psychologist Keith Conners Created to Study Methylphenidate, the Reason Post Secondary Educational Institutions Had to Request Methylphenidate From Chemische Industrie Basel, How Chemische Industrie Basel Transports Methylphenidate, the Original Name of “Attention Deficit Hyper Activity Disorder”, the Evolution of the Name of “Attention Deficit Hyper Activity Disorder”, the Possibility of This Evolution Being a Marketing Ploy, the Development of Dextroamphetamine-Amphetamine (Adderall), Methylphenidate vs Dextroamphetamine-Amphetamine, the Original Name of “Dextroamphetamine-Amphetamine”, the Total Annual Economic Value of Prescription Stimulants Within the U.S., the Reason Conners Regrets Researching Methylphenidate, the Only Countries Which Allow Pharmaceutical Marketing and Advertising, How Prescription Stimulants are Marketed Toward Parents, the Health Risks of Consuming Stimulant Medication, the Most Dangerous Pairing for Stimulant Medications, the Reason Overdose With Stimulants and Alcohol is Possible, the Volume of Patients Able to Consume Amphetamine Without Becoming Addicted, and the View of the Amphetamine Epidemic by Some U.S. Physicians